Anti-angiogenic treatment of endometriosis: biochemical aspects

Condition tags

MeSH descriptors

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

Cited by (19)

• Anti-angiogenesis effect and mechanism study of Huangzhi Neiyi capsule in a rat endometriosis model 2020
• The expression of vascular endothelial growth factor is affected by hypoxia inducible factor-1α in peritoneum of endometriosis mice treated with genistein 2016
• Novel Medical Treatment Modalities of Endometriosis 2015
• Macrophage migration inhibitory factor is involved in ectopic endometrial tissue growth and peritoneal-endometrial tissue interaction in vivo: a plausible link to endometriosis development 2014
• Can platelet indices be new biomarkers for severe endometriosis? 2014
• Wenshen Xiaozheng Tang suppresses the growth of endometriosis with an antiangiogenic effect 2013
• Macrophage migration inhibitory factor antagonist blocks the development of endometriosis in vivo 2012
• Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin 2011
• Antiangiogenic agents for endometriosis 2011
• Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis 2011
• MicroRNA signature and regulatory functions in the endometrium during normal and disease states 2008
• Angiogenesis and antiangiogenic therapy in endometriosis 2007
• Imbalance in the expression of the activating type I and the inhibitory type II interleukin 1 receptors in endometriosis 2007
• Increased expression of interleukin-1 receptor type 1 in active endometriotic lesions 2007
• [New insights into the pathophysiology of endometriosis] 2007
• A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy 2006
• Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model 2006
• Endostatin inhibits the growth of endometriotic lesions but does not affect fertility 2005
• Angiogenese und antiangiogene Therapien der Endometriose 2004

Source provenance

europepmc

last seen: 2026-10-19T06:17:24.038039+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-10-08T21:02:24.140261+00:00